Role of TLR3 Signaling in Control of HCV
TLR3 信号传导在 HCV 控制中的作用
基本信息
- 批准号:7367012
- 负责人:
- 金额:$ 12.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-15 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsAntiviral ResponseCellsChronicChronic HepatitisCirrhosisComplexDisruptionDouble-Stranded RNAGenesGoalsHepatitis CHepatitis C virusHepatocyteHost DefenseHuman VirusInfectionInterferon ActivationInterferonsInvestigationKnowledgeLeadLifeLiver diseasesMalignant neoplasm of liverMammalian CellMediatingNF-kappa BNatural ImmunityOutcomePathogenesisPathway interactionsPersonal SatisfactionPrimary carcinoma of the liver cellsRNA VirusesRNA replicationRecruitment ActivityResearchRoleSignal PathwaySignal TransductionSupporting CellTherapeutic InterventionTretinoinViralVirus DiseasesVirus Replicationanti-hepatitis Ccytokinedesignhuman IRF3 proteinhuman TLR3 proteininterferon regulatory factor-3neoplasticnovel therapeuticspathogenpermissivenessreconstitutionresponsesensortranscription factorviral RNAvirus host interaction
项目摘要
Innate cellular antiviral defenses are likely to influence the outcome of infections by many human viruses,
including hepatitis C virus (HCV), a positive strand RNA virus that frequently establishes persistent infections
leading to chronic hepatitis, cirrhosis and liver cancer. However, little is known about how hepatocytes sense
HCV infection and initiate protective responses. We have recently shown that non-neoplastic PH5CH8
hepatocytes contain two distinct antiviral signaling pathways, Toll-like receptor 3 (TLR3) and retinoic acid-
inducible gene I (RIG-I), to recognize viral double-stranded (ds) RNA and lead to subsequent interferon
antiviral response. Our long-term goal is to elucidate the role of these signaling pathways in hepatocellular
control of HCV infection. While RIG-I signaling was recently shown to contribute to sensing and limiting
intracellular HCV RNA replication, the role of TLR3 signaling in cellular recognition and control of HCV
infection remains unknown, as previous investigations were all conducted in hepatoma Huh7 cells which lack
a functional TLR3 pathway. We hypothesize that TLR3 signaling is an important antiviral mechanism of
hepatocytes, and contributes to host defenses against HCV by itself and/or in synergy with other antiviral
signaling mechanisms. We propose the following aims: 1. Determine whether TLR3 signaling contributes to
cellular control of HCV replication. 2. Determine whether HCV replication activates TLR3 signaling pathway
in hepatocytes. 3. Characterize the mechanisms of TLR3 signaling in hepatocytes. This proposed research
shall advance our knowledge regarding virus-host interactions in hepatitis C pathogenesis and the role of
innate immunity in controlling HCV infection, which would benefit the design of new therapeutic interventions
for HCV infection.
先天性细胞抗病毒防御可能会影响许多人类病毒感染的结果,
包括丙型肝炎病毒(HCV),一种经常引起持续感染的正链RNA病毒
导致慢性肝炎、肝硬化和肝癌。然而,关于肝细胞如何感知
HCV感染并启动保护性反应。我们最近发现,非肿瘤性PH 5CH 8
肝细胞含有两种不同的抗病毒信号通路,Toll样受体3(TLR 3)和视黄酸,
诱导基因I(RIG-I),识别病毒双链(ds)RNA并导致随后的干扰素
抗病毒反应我们的长期目标是阐明这些信号通路在肝细胞凋亡中的作用。
控制HCV感染。虽然RIG-I信号传导最近被证明有助于感知和限制
细胞内HCV RNA复制,TLR 3信号在细胞识别和控制HCV中的作用
感染仍然是未知的,因为以前的研究都是在肝肿瘤Huh 7细胞中进行的,
功能性TLR 3通路。我们假设TLR 3信号传导是一种重要的抗病毒机制,
肝细胞,并有助于宿主防御HCV本身和/或协同其他抗病毒药物
信号机制。我们提出以下目标:1.确定TLR 3信号传导是否有助于
HCV复制的细胞控制。2.确定HCV复制是否激活TLR 3信号通路
在肝细胞中。3.描述肝细胞中TLR 3信号传导的机制。这项拟议的研究
将促进我们对丙型肝炎发病机制中病毒-宿主相互作用以及
先天免疫在控制HCV感染中的作用,这将有利于设计新的治疗干预措施
HCV感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUI LI其他文献
KUI LI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUI LI', 18)}}的其他基金
Host genetic determinants regulating susceptibility/resistance to SARS-CoV-2
调节 SARS-CoV-2 易感性/耐药性的宿主遗传决定因素
- 批准号:
10673467 - 财政年份:2022
- 资助金额:
$ 12.69万 - 项目类别:
Host genetic determinants regulating susceptibility/resistance to SARS-CoV-2
调节 SARS-CoV-2 易感性/耐药性的宿主遗传决定因素
- 批准号:
10625449 - 财政年份:2022
- 资助金额:
$ 12.69万 - 项目类别:
Host genetic determinants regulating susceptibility/resistance to SARS-CoV-2
调节 SARS-CoV-2 易感性/耐药性的宿主遗传决定因素
- 批准号:
10510620 - 财政年份:2022
- 资助金额:
$ 12.69万 - 项目类别:
Role of TRIM56 in Antiviral Innate Immunity
TRIM56 在抗病毒先天免疫中的作用
- 批准号:
8510314 - 财政年份:2013
- 资助金额:
$ 12.69万 - 项目类别:
Role of TRIM56 in Antiviral Innate Immunity
TRIM56 在抗病毒先天免疫中的作用
- 批准号:
8604677 - 财政年份:2013
- 资助金额:
$ 12.69万 - 项目类别:
Role of TLR3 Signaling in Control of HCV
TLR3 信号传导在 HCV 控制中的作用
- 批准号:
8435728 - 财政年份:2007
- 资助金额:
$ 12.69万 - 项目类别:
Role of TLR3 Signaling in Control of HCV
TLR3 信号传导在 HCV 控制中的作用
- 批准号:
7772297 - 财政年份:2007
- 资助金额:
$ 12.69万 - 项目类别:
Role of TLR3 Signaling in Control of HCV
TLR3 信号传导在 HCV 控制中的作用
- 批准号:
8849812 - 财政年份:2007
- 资助金额:
$ 12.69万 - 项目类别:
Role of TLR3 Signaling in Control of HCV
TLR3 信号传导在 HCV 控制中的作用
- 批准号:
9064623 - 财政年份:2007
- 资助金额:
$ 12.69万 - 项目类别:
Role of TLR3 Signaling in Control of HCV
TLR3 信号传导在 HCV 控制中的作用
- 批准号:
8646846 - 财政年份:2007
- 资助金额:
$ 12.69万 - 项目类别:
相似海外基金
Regulation of RIG-I mediated antiviral response upon influenza A virus infection
RIG-I介导的甲型流感病毒感染抗病毒反应的调节
- 批准号:
494286 - 财政年份:2023
- 资助金额:
$ 12.69万 - 项目类别:
Operating Grants
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
- 批准号:
10364056 - 财政年份:2022
- 资助金额:
$ 12.69万 - 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10621913 - 财政年份:2022
- 资助金额:
$ 12.69万 - 项目类别:
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1 介导的寨卡病毒 (ZIKV) 感染抗病毒反应
- 批准号:
10373627 - 财政年份:2022
- 资助金额:
$ 12.69万 - 项目类别:
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
激活 DNA-PK 依赖性抗病毒反应作为一种新型癌症免疫疗法
- 批准号:
10553146 - 财政年份:2022
- 资助金额:
$ 12.69万 - 项目类别:
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection
AMPK 和 Hippo 信号传导之间的相互作用调节眼部对寨卡病毒感染的抗病毒反应
- 批准号:
10322026 - 财政年份:2021
- 资助金额:
$ 12.69万 - 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE介导的单核细胞抗病毒反应途径的调节机制
- 批准号:
10640247 - 财政年份:2021
- 资助金额:
$ 12.69万 - 项目类别:
Mechanisms of IgE-mediated regulation of monocyte antiviral response pathways
IgE 介导的单核细胞抗病毒反应途径调节机制
- 批准号:
10438876 - 财政年份:2021
- 资助金额:
$ 12.69万 - 项目类别:
Antiviral response coupled with transposon derepression in Alzheimer's disease and aging
抗病毒反应与转座子去抑制在阿尔茨海默病和衰老中的作用
- 批准号:
10629440 - 财政年份:2021
- 资助金额:
$ 12.69万 - 项目类别:
Epigenetic Control of Mucosal IRF1/IFN-III Antiviral Response by Enhancer-like Promoter and its Coding lncRNA
增强子样启动子及其编码lncRNA对粘膜IRF1/IFN-III抗病毒反应的表观遗传控制
- 批准号:
10373575 - 财政年份:2021
- 资助金额:
$ 12.69万 - 项目类别: